Related references
Note: Only part of the references are listed.Molecular basis of mycobacterial survival in macrophages
Jane Atesoh Awuh et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Pattern recognitions receptors in immunodeficiency disorders
Esameil Mortaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Divergent macrophage responses to Mycobacterium bovis among naturally exposed uninfected and infected cattle
Omar A. Alcaraz-Lopez et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
A new method to evaluate macaque health using exhaled breath: A case study of M-tuberculosis in a BSL-3 setting
Theodore R. Mellors et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Nanoparticulated Nitric Oxide Donors and their Biomedical Applications
Amedea B. Seabra et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
The PPE2 protein of Mycobacterium tuberculosis translocates to host nucleus and inhibits nitric oxide production
Khalid Hussain Bhat et al.
SCIENTIFIC REPORTS (2017)
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
Bibhuti B. Mishra et al.
NATURE MICROBIOLOGY (2017)
Badger macrophages fail to produce nitric oxide, a key antimycobacterial effector molecule
Kirstin Bilham et al.
SCIENTIFIC REPORTS (2017)
Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production
Hafij Al Mahmud et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
Guilherme Felipe dos Santos Fernandes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection
Christophe J. Queval et al.
SCIENTIFIC REPORTS (2016)
State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications
Arnedea B. Seabra et al.
BIOTECHNOLOGY ADVANCES (2015)
Treatment with topical nitroglycerine may promote the healing process of diabetic foot ulcers
Peyman Mikaili et al.
MEDICAL HYPOTHESES (2014)
Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy
Dmytro O. Butov et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2014)
The Intracellular Environment of Human Macrophages That Produce Nitric Oxide Promotes Growth of Mycobacteria
Joo-Yong Jung et al.
INFECTION AND IMMUNITY (2013)
Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis: Association With Disease Severity and Delayed Mycobacterial Clearance With Treatment
Anna P. Ralph et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1 beta
Bibhuti B. Mishra et al.
NATURE IMMUNOLOGY (2013)
Nitric Oxide Not Apoptosis Mediates Differential Killing of Mycobacterium bovis in Bovine Macrophages
Hugo Esquivel-Solis et al.
PLOS ONE (2013)
Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide
Amy Cunningham-Bussel et al.
MICROBIOLOGYOPEN (2013)
Inhalable Microparticles Containing Nitric Oxide Donors: Saying NO to Intracellular Mycobacterium tuberculosis
Rahul K. Verma et al.
MOLECULAR PHARMACEUTICS (2012)
Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
Jonna Idh et al.
PLOS ONE (2012)
Mycobacterial survival strategies in the phagosome: defence against host stresses
Sabine Ehrt et al.
CELLULAR MICROBIOLOGY (2009)
Structural Insights on the Mycobacterium tuberculosis Proteasomal ATPase Mpa
Tao Wang et al.
STRUCTURE (2009)
The Role of Nitric Oxide in Mycobacterial Infections
Chul-Su Yang et al.
Immune Network (2009)
Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824
Xiaojin Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
Jonna Idh et al.
BMC INFECTIOUS DISEASES (2008)
NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action
Basil Rigas et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis
Anna P. Ralph et al.
TRENDS IN MICROBIOLOGY (2008)
Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection
Deepak Jayakumar et al.
CELLULAR MICROBIOLOGY (2008)
Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis:: epidemiology and control
Alberto Matteelli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells
Kamalakannan Velmurugan et al.
PLOS PATHOGENS (2007)
Host innate immune response to Mycobacterium tuberculosis
Kamlesh Bhatt et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment
Edhyana Sahiratmadja et al.
INFECTION AND IMMUNITY (2007)
Identification of substrates of the Mycobacterium tuberculosis proteasome
Michael J. Pearce et al.
EMBO JOURNAL (2006)
Reference values for exhaled nitric oxide (reveno) study
Mario Olivieri et al.
RESPIRATORY RESEARCH (2006)
Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis
MC Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears
R Long et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
S-nitroso proteome of Mycobacterium tuberculosis:: Enzymes of intermediary metabolism and antioxidant defense
KY Rhee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tuberculosis - Metabolism and respiration in the absence of growth
HIM Boshoff et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Aerosolized gamma interferon (IFN-γ) induces expression of the genes encoding the IFN-γ-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis
B Raju et al.
INFECTION AND IMMUNITY (2004)
M-tuberculosis persistence, latency, and drug tolerance
JE Gomez et al.
TUBERCULOSIS (2004)
Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection
BH Miller et al.
INFECTION AND IMMUNITY (2004)
The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide
KH Darwin et al.
SCIENCE (2003)
Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis
HS Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro
MA Firmani et al.
INFECTION AND IMMUNITY (2002)
IFN-γ and NO in mycobacterial disease:: new jobs for old hands
AM Cooper et al.
TRENDS IN MICROBIOLOGY (2002)
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice
CA Scanga et al.
INFECTION AND IMMUNITY (2001)
What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge
ED Chan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Effects of Mycobacterium bovis BCG infection on regulation of L-arginine uptake and synthesis of reactive nitrogen intermediates in J774.1 murine macrophages
M Peteroy-Kelly et al.
INFECTION AND IMMUNITY (2001)
Induction of inducible nitric oxide synthase-NO• by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways
ED Chan et al.
INFECTION AND IMMUNITY (2001)
Granulysin, a T cell product, kills bacteria by altering membrane permeability
WA Ernst et al.
JOURNAL OF IMMUNOLOGY (2000)
Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB)
D Dlugovitzky et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung
AM Cooper et al.
INFECTION AND IMMUNITY (2000)
Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
C Nathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and Lyse infected macrophages
NV Serbina et al.
JOURNAL OF IMMUNOLOGY (2000)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
Nitric oxide modulates interleukin-1 beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis
HP Kuo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
